Companies in #Frontotemporal Dementia
Found 1 company operating in this sector.
Alector is a clinical-stage biotechnology company developing immuno-neurology therapies for neurodegenerative diseases. Its lead programs target progranulin (PGRN) and TREM2 pathways, with a major 2026 setback when partner GSK walked away from its $700M upfront Alzheimer's collaboration after consecutive clinical failures.